Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CASP6 | P55212 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.45 |
| ▸ | CCR1 | P32246 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL244724 | 0.87 | CYP1A2 (0.52) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL25105737 | 0.87 | CYP1A2 (0.52) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL13737910 | 0.84 | CYP1A2 (0.48) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL244649 | 0.84 | CYP1A2 (0.48) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL31254036 | 0.84 | PTPN1 (0.51) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL10259445 | 0.83 | CYP1A2 (0.68) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL9217980 | 0.80 | CYP1A2 (0.65) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL1562712 | 0.77 | CYP1A2 (0.61) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL862233 | 0.76 | CYP1A2 (0.60) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| SCHEMBL31186677 | 0.76 | CYP1A2 (0.60) | CYP1A2KDM4ELMNAPOLBCASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140311890-A1 | PHOTOACID COMPOUNDS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2014-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140311890-A1 | PHOTOACID COMPOUNDS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | PAM, PPOX, HCCS | CYP1A2 562/4885KDM4E 3712/4885LMNA 1781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.